Haemonetics (HAE) Current Assets (2010 - 2026)

Haemonetics' Current Assets history runs 17 years deep, the most recent figure standing at $834.9 million for Q1 2026.

• On a quarterly basis, Current Assets fell 10.71% year-over-year to $834.9 million in Q1 2026; TTM through Mar 2026 was $834.9 million, a 10.71% decrease from a year earlier, with the FY2026 full-year figure at $834.9 million, down 10.71% from the prior year.
• Current Assets retreated to $834.9 million in Q1 2026 per HAE's latest filing, from $943.7 million in the prior quarter.
• Across five years, Current Assets topped out at $1.0 billion in Q4 2024 and bottomed at $687.8 million in Q3 2022.
• The 5-year median for Current Assets is $818.2 million (2023), against an average of $835.2 million.
• Across the five-year window, Current Assets surged 31.49% in 2024 and retreated 10.71% in 2026, its largest moves.
• Year by year, Current Assets stood at $706.3 million in 2022, then rose by 8.31% to $765.0 million in 2023, then soared by 31.49% to $1.0 billion in 2024, then dropped by 6.18% to $943.7 million in 2025, then declined by 11.53% to $834.9 million in 2026.
• Per Business Quant, the three latest HAE Current Assets figures stand at $834.9 million (Q1 2026), $943.7 million (Q4 2025), and $899.7 million (Q3 2025).